RIPLE
LIVE

Serial Number

99348375

Owner

SonoThera, Inc.

Attorney

Dustin Luettgen

Filing Date

Aug 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RIPLE Trademark

Serial Number: 99348375

RIPLE is a trademark filed by SonoThera, Inc. on August 20, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SonoThera, Inc. (7 trademarks)

201 Haskins Way
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

August 20, 2025

Registration Date

Not Registered

Goods & Services

Medical services for ultrasound mediated administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.

Ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.

Gene therapy preparations, namely, biological preparations for the treatment of human diseases or disorders, namely, diseases of genetic or genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology; gene delivery platform, namely, biological delivery agents for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology

Software as a service for the operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.; Research and development in the field of gene therapy

Software for operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 20, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 9, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 20, 2025 MAFR
NEW APPLICATION ENTERED
Aug 20, 2025 NWAP